Advertisement

Preoperative Staging and Resectability Assessment of Pancreatic Cancer

  • Roberto Persiani
  • Alberto Biondi
  • Marco Zoccali
  • Domenico D’Ugo
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

Surgical resection is the most important aspect of therapy for pancreatic carcinoma. However, surgery is increasingly considered as a therapeutic option to be combined with other treatments such as chemotherapy and radiotherapy. This is especially true for locally advanced tumors, where surgical treatment alone does not typically result in a satisfactory rate of overall survival. For pancreatic carcinoma, as for other solid tumors, the therapeutic strategy depends on the stage of the disease, and accurate staging is mandatory before starting treatment. In the last 20 years, this strategy has promoted the development of more accurate and sophisticated staging techniques; historically, exploratory laparotomies accounted for up to 50% of the patients considered to be resectable at preoperative staging [1, 2, 3, 4], and modern multimodal treatments are diversified regardless of whether the tumor is resectable, locally advanced, or metastatic [5, 6].

Keywords

Pancreatic Cancer Superior Mesenteric Artery Pancreatic Carcinoma Pancreatic Adenocarcinoma Spiral Compute Tomography 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yeo CJ, Cameron JL (1999) Improving results of pancreaticoduodenectomy for pancreatic cancer. World J Surg 23:907–912CrossRefPubMedGoogle Scholar
  2. 2.
    Parker SL, Tong T, Bolden S et al (1996) Cancer statistics, 1996. CA Cancer J Clin 46:5–27CrossRefPubMedGoogle Scholar
  3. 3.
    Kalra MK, Maher MM, Mueller PR et al (2003) State-of-the-art imaging of pancreatic neoplasms. Br J Radiol 76:857–865CrossRefPubMedGoogle Scholar
  4. 4.
    Soriano A, Castells A, Ayuso C et al (2004) Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 99:492–501CrossRefPubMedGoogle Scholar
  5. 5.
    Liu RC, Traverso LW (2005) Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc 19:638–642CrossRefPubMedGoogle Scholar
  6. 6.
    Shoup M, Winston C, Brennan MF et al (2004) Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma? J Gastrointest Surg 8:1068–1071CrossRefPubMedGoogle Scholar
  7. 7.
    Minnard EA, Conlon KC, Hoos A et al (1998) Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer. Ann Surg 228:182–187CrossRefPubMedGoogle Scholar
  8. 8.
    Merchant NB, Conlon KC (1998) Laparoscopic evaluation in pancreatic cancer. Semin Surg Oncol 15:155–165CrossRefPubMedGoogle Scholar
  9. 9.
    Cuschieri A, Hall AW, Clark J (1978) Value of laparoscopy in the diagnosis and management of pancreatic carcinoma. Gut 19:672–677CrossRefPubMedGoogle Scholar
  10. 10.
    Nieveen van Dijkum EJ, Romijn MG, Terwee CB et al (2003) Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg 237:66–73CrossRefPubMedGoogle Scholar
  11. 11.
    Katz MH, Hwang R, Fleming JB et al (2008) Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin 58:111–125CrossRefPubMedGoogle Scholar
  12. 12.
    National Comprehensive Cancer Network (2008) NCCN practice guidelines for pancreatic cancer. Available at: http://www.nccn.org. Accessed May 2008Google Scholar
  13. 13.
    Varadhachary GR, Tamm EP, Abbruzzese JL et al (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035–1046CrossRefPubMedGoogle Scholar
  14. 14.
    Lawson TL (1978) Sensitivity of pancreatic ultrasonography in the detection of pancreatic disease. Radiology 128:733–736PubMedGoogle Scholar
  15. 15.
    Taylor KJW, Buchin PJ, Viscomi GN et al (1981) Ultrasonographic scanning of the pancreas. Radiology 138:211–213PubMedGoogle Scholar
  16. 16.
    Pasanen PA, Partanen KP, Pikkarainen PH et al (1993) A comparison of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the differential diagnosis of benign and malignant jaundice and cholestasis. Eur J Surg 159:23–29PubMedGoogle Scholar
  17. 17.
    Karlson BM, Ekbom A, Lindgren PG et al (1999) Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. Radiology 213:107–111PubMedGoogle Scholar
  18. 18.
    Michl P, Pauls S, Gress TM (2006) Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol 20:227–251CrossRefPubMedGoogle Scholar
  19. 19.
    Clarke DL, Thomson SR, Madiba TE et al (2003) Preoperative imaging of pancreatic cancer: a management-oriented approach. J Am Coll Surg 196:119–129CrossRefPubMedGoogle Scholar
  20. 20.
    Tomiyama T, Ueno N, Tano S et al (1996) Assessment of arterial invasion in pancreatic cancer using color Doppler ultrasonography. Am J Gastroenterol 91:1410–1416PubMedGoogle Scholar
  21. 21.
    Morrin MM, Kruskal JB, Raptopoulos V et al (2001) State-of-the-art ultrasonography is as accurate as helical computed tomography and computed tomographic angiography for detecting unresectable periampullary cancer. J Ultrasound Med 20:481–490PubMedGoogle Scholar
  22. 22.
    Rosch T, Lightdale CJ, Botet JF et al (1992) Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 326:1721–1726PubMedGoogle Scholar
  23. 23.
    Yasuda K, Mukai H, Nakajima M (1995) Endoscopic ultrasonography diagnosis of pancreatic cancer. Gastrointest Endosc Clin N Am 5:699–712PubMedGoogle Scholar
  24. 24.
    Hunt GC, Faigel DO (2002) Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc 55:232–237CrossRefPubMedGoogle Scholar
  25. 25.
    Kulig J, Popiela T, Zajac A et al (2005) The value of imaging techniques in the staging of pancreatic cancer. Surg Endosc 19:361–365CrossRefPubMedGoogle Scholar
  26. 26.
    Buscail L, Pages P, Berthelemy P et al (1999) Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis. Gastrointest Endosc 50:34–40CrossRefPubMedGoogle Scholar
  27. 27.
    Ahmad NA, Lewis JD, Ginsberg GG et al (2000) EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 52:463–468CrossRefPubMedGoogle Scholar
  28. 28.
    Akahoshi K, Chijiiwa Y, Nakano I et al (1998) Diagnosis and staging of pancreatic cancer by endoscopic ultrasound. Br J Radiol 71:492–496PubMedGoogle Scholar
  29. 29.
    Rosch T, Braig C, Gain T et al (1992) Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 102:188–199PubMedGoogle Scholar
  30. 30.
    Muller MF, Meyenberger C, Bertschinger P et al (1994) Pancreatic tumors: evaluation with endoscopic US, CT and MR imaging. Radiology 190:745–751PubMedGoogle Scholar
  31. 31.
    Midwinter MJ, Beveridge CJ, Wilsdon JB et al (1999) Correlation between spiral comuted tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 86:189–193CrossRefPubMedGoogle Scholar
  32. 32.
    Brugge WR, Lee MJ, Kelsey PB et al (1996) The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc 43:561–567CrossRefPubMedGoogle Scholar
  33. 33.
    Aslanian H, Salem R, Lee J et al (2005) EUS diagnosis of vascular invasion in pancreatic cancer: surgical and histologic correlates. Am J Gastroenterol 100:1381–1385CrossRefPubMedGoogle Scholar
  34. 34.
    Sahani DV, Shah ZK, Catalano OA et al (2008) Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 23:23–33CrossRefPubMedGoogle Scholar
  35. 35.
    Rösch T, Lorenz R, Braig C et al (1991) Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 37:347–352CrossRefPubMedGoogle Scholar
  36. 36.
    Grimm H, Binmoeller KF, Soehendra N (1992) Endosonography-guided drainage of a pancreatic pseudocyst. Gastrointest Endosc 38:170–171CrossRefPubMedGoogle Scholar
  37. 37.
    Erickson RA (2004) EUS-guided FNA. Gastrointest Endosc 60:267–279CrossRefPubMedGoogle Scholar
  38. 38.
    Wiersema MJ, Vilmann P, Giovannini M et al (1997) Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 112:1087–1095CrossRefPubMedGoogle Scholar
  39. 39.
    Dupuy DE, Costello P, Ecker CP (1992) Spiral CT of the pancreas. Radiology 183:815–818PubMedGoogle Scholar
  40. 40.
    Taoka H, Hauptmann E, Traverso LW et al (1999) How accurate is helical computed tomography for clinical staging of pancreatic cancer? Am J Surg 177:428–432CrossRefPubMedGoogle Scholar
  41. 41.
    Bluemke DA, Cameron JL, Hruban RH et al (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385PubMedGoogle Scholar
  42. 42.
    Phoa SSKS, Reeders JWAJ, Rauws EAJ (1999) Spiral computed tomography for preoperative staging of potentially resectable carcinoma of the pancreatic head. Br J Surg 86:789–794CrossRefPubMedGoogle Scholar
  43. 43.
    Vendenthan S, LU DSK, Reber HA et al (1998) Small peripancreatic veins; improved assessment in pancreatic cancer patients using thin section pancreatic phase helical CT. AJR Am J Roentgenol 170:377–383Google Scholar
  44. 44.
    Horton KM, Fishman EK (2000) 3D CT angiography of the celiac and superior mesenteric arteries with multidetector CT data sets: preliminary observations. Abdom Imaging 25:523–525CrossRefPubMedGoogle Scholar
  45. 45.
    Fishman EK, Horton KM, Urban BA (2000) Multidetector CT angiography in the evaluation of pancreatic carcinoma: preliminary observations. J Comput Assist Tomogr 24:849–853CrossRefPubMedGoogle Scholar
  46. 46.
    Bronstein YL, Loyer EM, Kaur H et al (2004) Detection of small pancreatic tumors with multiphasic helical CT. Am J Roentgenol 182:619–623Google Scholar
  47. 47.
    Li H, Zeng MS, Zhou KR et al (2005) Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr 29:170–175CrossRefPubMedGoogle Scholar
  48. 48.
    Prokesch RW, Chow LC, Beaulieu CF et al (2002) Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations — initial experience. Radiology 225:759–765CrossRefPubMedGoogle Scholar
  49. 49.
    Furukawa H, Uesaka K, Boku N (2008) Treatment decision making in pancreatic adenocarcinoma: multidisciplinary team discussion with multidetector-row computed tomography. Arch Surg 143:275–280CrossRefPubMedGoogle Scholar
  50. 50.
    Roche CJ, Hughes ML, Garvey CJ et al (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 180:475–480PubMedGoogle Scholar
  51. 51.
    Pisters PW, Lee JE, Vauthey JN et al (2001) Laparoscopy in the staging of pancreatic cancer. Br J Surg 88:325–337CrossRefPubMedGoogle Scholar
  52. 52.
    Megibow AJ, Zhou XH, Rotterdam H et al (1995) Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability: report of the radiology diagnostic oncology group. Radiology 195:327–332PubMedGoogle Scholar
  53. 53.
    Ichikawa T, Haradome H, Hachiya J et al (1997) Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 202:655–662PubMedGoogle Scholar
  54. 54.
    Semelka RC, Ascher SM (1993) MR imaging of the pancreas. Radiology 188:593–602PubMedGoogle Scholar
  55. 55.
    Saisho H, Yamaguchi T (2004) Diagnostic imaging for pancreatic cancer: computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas 28:273–278CrossRefPubMedGoogle Scholar
  56. 56.
    Pamuklar E, Semelka RC (2005) MR imaging of the pancreas. Magn Reson Imaging Clin N Am 13:313–330CrossRefPubMedGoogle Scholar
  57. 57.
    Semelka RC, Shouenut JP, Kroeker MA (1993) Chronic pancreatitis: MRI features before and after administration of gadopentate dimeglumine. J Magn Reson Imaging 3:79–82CrossRefPubMedGoogle Scholar
  58. 58.
    Wallner BK, Schumaker KA, Weidenmaier W et al (1991) Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrast-enhanced fast sequence. Radiology 181:805–808PubMedGoogle Scholar
  59. 59.
    Mehta SN, Reinhold C, Barkun AN (1997) Magnetic resonance cholangiopancreatography. Gastrointest Endosc Clin N Am 7:247–270PubMedGoogle Scholar
  60. 60.
    Adamek H, Albert J, Breer H et al (2000) Pancreatic cancer detection with MR cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 356:190–193CrossRefPubMedGoogle Scholar
  61. 61.
    Lee MG, Lee HJ, Kim MH et al (1997) Extrahepatic biliary diseases: 3D MR cholangiopancreatography compared with endoscopic retrograde cholangiopancreatography. Radiology 202:663–669PubMedGoogle Scholar
  62. 62.
    Hirschowitz BI, Curtiss LE, Peters CW et al (1958) Demonstration of a new gastroscope, the “fiberscope”. Gastroenterology 35:50PubMedGoogle Scholar
  63. 63.
    Siegel JH (1992) Endoscopic retrograde cholangiopancreatography. Technique, diagnosis and therapy. Raven, New YorkGoogle Scholar
  64. 64.
    Niederau C, Grendell JH (1992) Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas 7:66–86PubMedCrossRefGoogle Scholar
  65. 65.
    Aly EA, Johnson CD (2001) Preoperative biliary drainage before resection in obstructive jaundice. Dig Surg 18:84–89CrossRefPubMedGoogle Scholar
  66. 66.
    Flamm CR, Mark DH, Aronson N (2002) Evidence-based assessment of ERCP approaches to managing pancreaticobiliary malignancies. Gastrointest Endosc 56(6Suppl):S218–S225CrossRefPubMedGoogle Scholar
  67. 67.
    Strasberg SM (2002) ERCP and surgical intervention in pancreatic and biliary malignancies. Gastrointest Endosc 56:S213–S217CrossRefPubMedGoogle Scholar
  68. 68.
    Keogan MT, Tyler D, Clark L et al (1998) Diagnosis of pancreatic carcinoma: role of FDG PET. AJR Am J Roentgenol 171:1565–1570PubMedGoogle Scholar
  69. 69.
    Sendler A, Avril N, Helmberger H et al (2000) Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations. World J Surg 24:1121–1129CrossRefPubMedGoogle Scholar
  70. 70.
    Rose DM, Delbeke D, Beauchamp RD et al (1999) 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 229:729–737CrossRefPubMedGoogle Scholar
  71. 71.
    Friess H, Langhans J, Ebert M et al (1995) Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-d-glucose positron emission tomography. Gut 36:771–777CrossRefPubMedGoogle Scholar
  72. 72.
    Annovazzi A, Peeters M, Maenhout A et al (2003) 18-Fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract. Gastroenterology 125:1235–1245CrossRefPubMedGoogle Scholar
  73. 73.
    Diederichs CG, Staib L, Vogel J et al (2000) Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20:109–116CrossRefPubMedGoogle Scholar
  74. 74.
    Heinrich S, Goerres GW, Schafer M et al (2005) Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 242:235–243CrossRefPubMedGoogle Scholar
  75. 75.
    Bernheim BM (1911) Organoscopy: cystoscopy of the abdominal cavity. Ann Surg 53:764–767CrossRefPubMedGoogle Scholar
  76. 76.
    Cuschieri A, Hall AW, Clark J (1978) Value of laparoscopy in the diagnosis and management of pancreatic carcinoma. Gut 19:672–677CrossRefPubMedGoogle Scholar
  77. 77.
    Stefanidis D, Grove KD, Schwesinger WH et al (2006) The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Ann Oncol 17:189–199CrossRefPubMedGoogle Scholar
  78. 78.
    White R, Winston C, Gonen M, D’Angelica et al (2008) Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. J Am Coll Surg 206:445–450CrossRefPubMedGoogle Scholar
  79. 79.
    Conlon KC, Dougherty E, Klimstra DS et al (1996) The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg 223:134–140CrossRefPubMedGoogle Scholar
  80. 80.
    Leach SD, Rose JA, Lowy AM et al (1995) Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery 82:472–478CrossRefGoogle Scholar
  81. 81.
    Merchant NB, Conlon KC, Saigo P et al (1999) Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma. J Am Coll Surg 188:421–426CrossRefPubMedGoogle Scholar
  82. 82.
    Nakao A, Oshima K, Takeda S et al (1999) Peritoneal washings cytology combined with immunocytochemical staging in pancreatic cancer. Hepatogastroenterology 46:2974–2977PubMedGoogle Scholar
  83. 83.
    Yachida S, Fukushima N, Sakamoto M et al (2002) Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer. Br J Surg 89:573–578CrossRefPubMedGoogle Scholar
  84. 84.
    Yamada S, Takeda S, Fujii T et al (2007) Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis. Ann Surg 246:254–258CrossRefPubMedGoogle Scholar
  85. 85.
    Berber E, Garland AM, Engle KL et al (2004) Laparoscopic ultrasonography and biopsy of hepatic tumor in 310 patients. Am J Surg 187:213–218CrossRefPubMedGoogle Scholar
  86. 86.
    Charukhchyan SA, Lucas GW (1998) Laparoscopy and lesser sac endoscopy in gastric carcinoma operability assessment. Am Surg 64:160–164PubMedGoogle Scholar
  87. 87.
    Jaeck D, Boudjema K, Bachellier P et al (1998) Exeresi pancreatiche cefaliche: duodenocefalo-pancreasectomie (DCP). In: Encyclopédie médico chirurgicale: Tecniche chirurgiche — Addominale. Elsevier, Paris, 40-880-B, 17 pGoogle Scholar
  88. 88.
    Brown KM, Siripurapu V, Davidson M et al (2008) Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma. Am J Surg 195:318–321CrossRefPubMedGoogle Scholar
  89. 89.
    Verslype C, Van Cutsem E, Dicato M et al (2007) The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006. Ann Oncol 18(Suppl 7):vii1–vii10CrossRefPubMedGoogle Scholar
  90. 90.
    Crane CH, Varadhachary G, Pisters PW et al (2007) Future chemoradiation strategies in pancreatic cancer. Semin Oncol 34:335–346CrossRefPubMedGoogle Scholar
  91. 91.
    Russo S, Butler J, Ove R et al (2007) Locally advanced pancreatic cancer: a review. Semin Oncol 34:327–334CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Roberto Persiani
    • 1
  • Alberto Biondi
    • 1
  • Marco Zoccali
    • 1
  • Domenico D’Ugo
    • 1
  1. 1.Department of General Surgery, Medical School A. GemelliUniversity of the Sacred HeartRomeItaly

Personalised recommendations